Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Biol. Chem. 276 (24): 21916-21923

© 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Kinase Insert Domain Receptor (KDR) Extracellular Immunoglobulin-like Domains 4-7 Contain Structural Features That Block Receptor Dimerization and Vascular Endothelial Growth Factor-induced Signaling*

Qi TaoDagger , Marina V. Backer§, Joseph M. Backer§, and Bruce I. TermanDagger

From the Dagger  Cardiology Division, Department of Medicine, and the Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461 and § Sibtech, Newington, Connecticut 06111

The vascular endothelial growth factor (VEGF) receptor tyrosine kinase subtype kinase insert domain receptor (KDR) contains seven extracellular Ig-like domains, of which the three most amino-terminal contain the necessary structural features required for VEGF binding. To clarify the functional role of KDR Ig-like domains 4-7, we compared VEGF-induced signaling in human embryonic kidney and porcine aortic endothelial cells expressing native versus mutant receptor proteins in which Ig-like domains 4-7, 4-6, or 7 had been deleted. Western blotting using an anti-receptor antibody indicated equivalent expression levels for each of the recombinant proteins. As expected, VEGF treatment robustly augmented native receptor autophosphorylation. In contrast, receptor autophosphorylation, as well as downstream signaling events, were VEGF-independent for cells expressing mutant receptors. 125I-VEGF165 bound with equal or better affinity to mutant versus native receptor, although the number of radioligand binding sites was significantly reduced because a significant percentage of mutant, but not native, receptors were localized to the cell interior. As was the case for native KDR, 125I-VEGF165 binding to the mutant receptors was dependent upon cell surface heparan sulfate proteoglycans, and 125I-VEGF121 bound with an affinity equal to that of 125I-VEGF165 to the native and mutant receptors. It is concluded that KDR Ig-like domains 4-7 contain structural features that inhibit receptor signaling by a mechanism that is independent of neuropilin-1 and heparan sulfate proteoglycans. We speculate that this provides a cellular mechanism for blocking unwanted signaling events in the absence of VEGF.


* This work was supported in part by National Institutes of Health Grant R01 CA86289-01.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Cardiology Division, Dept. of Medicine, Forchheimer 715, 1300 Morris Park Ave., Bronx, NY 10461. Tel.: 718-430-2774; Fax: 718-430-8989; E-mail: terman@aecom.yu.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Targeting Extracellular Domains D4 and D7 of Vascular Endothelial Growth Factor Receptor 2 Reveals Allosteric Receptor Regulatory Sites.
C. A. C. Hyde, A. Giese, E. Stuttfeld, J. Abram Saliba, D. Villemagne, T. Schleier, H. K. Binz, and K. Ballmer-Hofer (2012)
Mol. Cell. Biol. 32, 3802-3813
   Abstract »    Full Text »    PDF »
Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization.
M. S. Brozzo, S. Bjelic, K. Kisko, T. Schleier, V.-M. Leppanen, K. Alitalo, F. K. Winkler, and K. Ballmer-Hofer (2012)
Blood 119, 1781-1788
   Abstract »    Full Text »    PDF »
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.
T. Ozawa, C. W. Brennan, L. Wang, M. Squatrito, T. Sasayama, M. Nakada, J. T. Huse, A. Pedraza, S. Utsuki, Y. Yasui, et al. (2010)
Genes & Dev. 24, 2205-2218
   Abstract »    Full Text »    PDF »
Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers.
D. Dell'Era Dosch and K. Ballmer-Hofer (2010)
FASEB J 24, 32-38
   Abstract »    Full Text »    PDF »
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model.
F. Mac Gabhann and A. S. Popel (2005)
Am J Physiol Heart Circ Physiol 288, H2851-H2860
   Abstract »    Full Text »    PDF »
Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium.
P. C. Colombo, A. W. Ashton, S. Celaj, A. Talreja, J. E. Banchs, N. B. Dubois, M. Marinaccio, S. Malla, J. Lachmann, J. A. Ware, et al. (2002)
J Appl Physiol 92, 1331-1338
   Abstract »    Full Text »    PDF »
Vascular Endothelial Growth Factor 165 (VEGF165) Activities Are Inhibited by Carboxymethyl Benzylamide Dextran That Competes for Heparin Binding to VEGF165 and VEGF165{middle dot}KDR Complexes.
Y. Hamma-Kourbali, R. Vassy, A. Starzec, V. Le Meuth-Metzinger, O. Oudar, R. Bagheri-Yarmand, G. Perret, and M. Crepin (2001)
J. Biol. Chem. 276, 39748-39754
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882